Business · 1 sources covering this

Aurobindo Pharma enters US inhalation market with generic Advair launch

The launch marks Aurobindo Pharma's entry into the US inhalation market and expands its complex generics portfolio beyond conventional oral solid formulations

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·1h ago
Aurobindo Pharma enters US inhalation market with generic Advair launch
The launch marks Aurobindo Pharma's entry into the US inhalation market and expands its complex generics portfolio beyond conventional oral solid formulations
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/a6838310d35f20a0ed57df30d1515d233df95170"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Aurobindo Pharma enters US inhalation market with generic Advair launch"></iframe>

Aurobindo Pharma enters US inhalation market with generic Advair launch

How 1 sources are covering this

Aurobindo Pharma enters US inhalation market with generic Advair launch

More from Business

NIIF raises $2 billion towards Infra Fund 2's first close, largest till date

Why India may revive 'Most-Favoured-Nation' rule in bilateral treaties

AI cyber biggest threat to financial stability

Ram Gopal Varma’s 'Dhurandhar' Praise Post Has Fans Asking: Is It A Dig At 'Toxic'?

Reader

Trust & legal

Across the network